Provided by Tiger Fintech (Singapore) Pte. Ltd.

FANGZHOU JIANKE

3.260
-0.060-1.81%
Volume:1.65M
Turnover:5.49M
Market Cap:4.37B
PE:-3.40
High:3.420
Open:3.320
Low:3.260
Close:3.320
52wk High:7.800
52wk Low:1.600
Shares:1.34B
HK Float Shares:1.34B
Volume Ratio:0.51
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.959
ROE:--
ROA:0.32%
PB:26.61
PE(LYR):-3.40
PS:1.39

Loading ...

"AI Weight Loss Consultant" Debuts at CIIE! FANGZHOU JIANKE (06086) and Novo-Nordisk A/S (NVO.US) Collaborate to Build a New Ecosystem for Chronic Disease Management in the "AI + Glycemic Control & Weight Loss" Sector

Stock News
·
Nov 10

Fangzhou Inc. (06086) Announces Share Capital Status for October 2025

Bulletin Express
·
Nov 03

FANGZHOU JIANKE (06086)'s "XingJie AI Model" Completes National Filing, Injecting New Momentum into AI+ Chronic Disease Management

Stock News
·
Nov 02

Breaking Boundaries with AI: FANGZHOU JIANKE (06086) and FOSUN PHARMA (02196) Forge Strategic Partnership to Build a Digital Ecosystem for Psoriasis Management

Stock News
·
Oct 29

Fangzhou and Fosun Pharma Launch AI-Powered Psoriasis Management Partnership

Reuters
·
Oct 29

Promoting Healthy China: "AI + Weight Loss" Implementation by FANGZHOU JIANKE (06086) Unlocks Ecological Value and Growth Potential

Stock News
·
Oct 23

AI-Driven Weight Management Enters National-Level Arena: "Healthy China • AI + Weight Management Initiative" Seminar Held in Beijing; First National-Level Platform for Weight Loss Launched

Stock News
·
Oct 23

Have Insiders Sold Fangzhou Shares Recently?

Simply Wall St.
·
Oct 06

Fangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care

GlobeNewswire
·
Sep 26

Hong Kong Stock Movement | FANGZHOU JIANKE (06086) Surges Over 8% as Xingshi Medical Large Model Featured in Nature News, Company's AI Chronic Disease Management Model Gains Global Recognition

Stock News
·
Sep 26

Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025

GlobeNewswire
·
Sep 18

Fangzhou Wins Gilead ‘Award of Excellence’ for AI-Driven Chronic Disease Management

GlobeNewswire
·
Sep 18

Fangzhou Inc. reagiert auf jüngste Kursbewegungen ihrer Aktie

Reuters
·
Sep 15

Hong Kong Stock Market Early Brief | China and US to Hold Talks in Spain on Tariffs, TikTok and Other Trade Issues

Stock News
·
Sep 15

Fangzhou Inc. reagiert auf jüngste Kursbewegung der eigenen Aktie

Reuters
·
Sep 14

Fangzhou Unveils “XingShi” LLM to Advance AI-Driven Chronic Disease Management

GlobeNewswire
·
Sep 14

Fangzhou Says in Partnership With Innovent to Integrate Co's H2h Digital Health Ecosystem With Innovent's Pipeline of Weight-Management Therapies

THOMSON REUTERS
·
Sep 14

BRIEF-Fangzhou Launches “Xingshi” LLM, Says in Innovent, Otsuka Tie-up

Reuters
·
Sep 14

Fangzhou Says in Collaboration With Zhejiang Otsuka Pharmaceutical to Jointly Develop Comprehensive Digital Solutions

THOMSON REUTERS
·
Sep 14

Fangzhou Inc Says Co Has Launched Its Proprietary “Xingshi” Large Language Model

THOMSON REUTERS
·
Sep 14